YAP1 and neoplasm: Oncogenic mutant p53, acting as a positive transcriptional cofactor for SREBPs, leads to the increased mevalonic acid and promotes YAP activity in tumour cells.17 These results reveal a tight connection between YAP activity and cell lipid and cholesterol metabolism.